Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications

Cell Immunol. 2018 Apr:326:68-76. doi: 10.1016/j.cellimm.2017.08.009. Epub 2017 Sep 11.

Abstract

In the recent years, many studies have shown that MSCs must be stimulated by pro-inflammatory cytokines or other immune mediators before they can modulate immune cells in inflamed and damaged tissues. MSCs appear to be involved in inducing several regulatory immune cells, such as Tregs, Bregs, and regulatory NK cells. This new immune milieu created by MSCs may establish a tolerogenic environment that leads to an optimal condition for the treatment of immune diseases. The mechanisms of MSC action to treat immune disorders need to be further investigated in more detail. Since there have been some contradictory outcomes of clinical trials, it is necessary to perform large-scale and randomized clinical studies, such as a phase 3 placebo-controlled double-blind study of a third party MSCs to optimize MSC administration and to prove safety and efficacy of MSC treatment. MSCs offer great therapeutic promise, especially for the treatment of difficult-to-treat immune diseases.

Keywords: Immune diseases; Immunomodulation; Mesenchymal stem cells; Regulatory immune cells.

Publication types

  • Review

MeSH terms

  • B-Lymphocytes, Regulatory / immunology
  • Cell Differentiation / immunology*
  • Cytokines / immunology*
  • Humans
  • Immunomodulation / immunology*
  • Killer Cells, Natural / immunology
  • Mesenchymal Stem Cell Transplantation / methods*
  • Mesenchymal Stem Cells / immunology*
  • Models, Immunological
  • T-Lymphocytes, Regulatory / immunology

Substances

  • Cytokines